Delivery Order SPE2DB24D2011-SPE2DB25FBRTA
- Not listed
- The Defense Logistics Agency awarded a $1,926.40 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack). This firm fixed price, non-set-aside contract is scheduled for completion by September 4, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs, likely for military or veteran...
- The Defense Logistics Agency awarded a $1,547.00 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (two-pack units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 21, 2025, and performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a short-duration, high-velocity procurement typical of the company's...
- The Defense Logistics Agency awarded a $1,413.12 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack). This firm fixed-price contract, with an ultimate completion date of August 6, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The award was competitively made with no set-aside designation, and performance will occur at the contractor's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack configuration) with a ceiling value of $4,079.52. This non-competed delivery order utilizes firm fixed pricing and is scheduled for completion by August 12, 2025. The contract is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.05 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, valued at $1,595.49. This is a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,626.84 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (two-pack units). This firm fixed-price contract, which is not set-aside, will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The delivery order was competitively awarded and represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epinephrine 0.15 mg auto-injector two-packs, with a contract ceiling value of $1,872.45. This is a firm fixed-price delivery order with no set-aside designation, executed on a competitive basis. The order is scheduled for ultimate completion by August 12, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) with a ceiling value of $1,086.91. This is a firm fixed-price delivery order with a completion date of September 5, 2025, and represents a competitively awarded contract with no set-aside designation. The award was fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,069.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for 0.15 mg epinephrine auto-injectors (2-pack) on September 3, 2025, with completion targeted for September 4, 2025. This non-set-aside delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRTADelivery Order
The Defense Logistics Agency awarded a $4,691.95 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (two-pack units). This firm fixed-price, non-set-aside contract is scheduled for completion by September 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a time-sensitive pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The parent contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 9/4/25 |